<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01594697</url>
  </required_header>
  <id_info>
    <org_study_id>000082011</org_study_id>
    <nct_id>NCT01594697</nct_id>
  </id_info>
  <brief_title>Metformin in Pregnancy in Women With Polycystic Ovary Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <brief_summary>
    <textblock>
      The study provide a detailed longitudinal evaluation of the gluco-insulinemic assessment of&#xD;
      pregnant PCOS women under metformin treatment. 47 non diabetic Polycystic Ovary Syndrome&#xD;
      (PCOS) women became pregnant during metformin treatment and continued taking the drug during&#xD;
      gestation. An oral glucose tolerance test and euglycaemic hyperinsulinaemic clamp were&#xD;
      performed at each trimester of gestation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of gestational diabetes</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of spontaneous abortion</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of hypertensive disorders</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of live births</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of newborns with macrosomia</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of delivery by caesarian section</measure>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <arm_group_label>metformin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-40 yr,&#xD;
&#xD;
          -  metformin treatment for at least 3 months before entering the pregnancy,&#xD;
&#xD;
          -  gestational age between 5 and 12 wk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diabetes mellitus&#xD;
&#xD;
          -  significant liver or renal impairment&#xD;
&#xD;
          -  neoplasms and other endocrine diseases&#xD;
&#xD;
          -  the use of drugs other than metformin able to interfere with glucose and insulin&#xD;
             metabolism.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University of Sacred Heart</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <study_first_submitted>May 7, 2012</study_first_submitted>
  <study_first_submitted_qc>May 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2012</study_first_posted>
  <last_update_submitted>May 10, 2012</last_update_submitted>
  <last_update_submitted_qc>May 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Maurizio Guido</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

